Christopher F. Wyatt - 05 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Feb 2026, 18:13:45 UTC
Prior SEC filing
02 Feb 2026
Next SEC filing
12 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Christopher F. Wyatt filed Form 4 for HCA Healthcare, Inc. (HCA) on 09 Feb 2026.

Key facts

  • This page summarizes Christopher F. Wyatt's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 09 Feb 2026, 18:13.

Change

  • Previous filing in this sequence was filed on 02 Feb 2026.
  • Current net transaction value: -$1,431,304.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673365 Primary reporting owner

Wyatt Christopher F.

Relationship
SVP & Controller
Address
ONE PARK PLAZA, NASHVILLE
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Signature date
09 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Options Exercise

Transaction value
$1,483,770
Shares
+10,670
Change %
+26%
Price
$139.06
Shares after
51,737
Date
05 Feb 2026
Ownership
Direct
HCA transaction

Common Stock

Tax liability

Transaction value
$2,915,074
Shares
-5,674
Change %
-11%
Price
$513.76
Shares after
46,063
Date
05 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
$0
Shares
-10,670
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,670
Exercise price
$139.06
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .